Provention Bio Inc. (PRVB) Tops Q3 EPS by 8c

Provention Bio Inc. (NASDAQ: PRVB) reported Q3 EPS of ($0.43), $0.08 better than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Provention Bio Inc. (PRVB) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• Absci, FuelCell Energy surge premarket; Cerebras, FedEx tumble
• NXP Semiconductors names Mike Lucarelli as new investor relations head